Literature DB >> 19246734

The need for multiple doses of 400 mg ketoconazole as a precipitant inhibitor of a CYP3A substrate in an in vivo drug-drug interaction study.

Charles Oo, Ya-Chi Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19246734     DOI： 10.1177/0091270008325931

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  3 in total

Review 1.  Quantitative clinical pharmacology is transforming drug regulation.

Authors:  Carl C Peck
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-10-27       Impact factor: 2.745

2.  Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects.

Authors:  Richat Abbas; Bruce A Hug; Cathie Leister; Jaime Burns; Daryl Sonnichsen
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

3.  Effect of ketoconazole on the pharmacokinetic profile of buprenorphine following administration of a once-weekly buprenorphine transdermal system.

Authors:  Ram P Kapil; Alessandra Cipriano; Gregory H Michels; Peter Perrino; Sarah A O'Keefe; Manjunath S Shet; Salvatore V Colucci; Robert J Noveck; Stephen C Harris
Journal:  Clin Drug Investig       Date:  2012-09-01       Impact factor: 2.859
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.